(Q41058411)

26 September 2017

1 reference

title

Progress and challenges toward an AIDS vaccine: Brother, can you spare a paradigm? (English)

1 reference

26 September 2017

0 references

W C Koff

1

1 reference

26 September 2017

A M Schultz

series ordinal

2

1 reference

26 September 2017

publication date

1 May 1996

1 reference

Journal of Clinical Immunology

26 September 2017

published in

1 reference

26 September 2017

volume

16

1 reference

26 September 2017

issue

3

1 reference

26 September 2017

page(s)

127-133

1 reference

https://scigraph.springernature.com/pub.10.1007/bf01540910

26 September 2017

exact match

0 references

cites work

HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women

1 reference

12 December 2020

Human trials of experimental AIDS vaccines

1 reference

12 December 2020

Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome

1 reference

12 December 2020

The next steps toward a global AIDS vaccine

1 reference

12 December 2020

Infection of cynomolgus monkeys with HIV-2 protects against pathogenic consequences of a subsequent simian immunodeficiency virus infection.

1 reference

12 December 2020

Vaccine protection against simian immunodeficiency virus infection

1 reference

12 December 2020

Engineering poliovirus as a vaccine vector for the expression of diverse antigens

1 reference

12 December 2020

Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection

1 reference

12 December 2020

Studies in subjects with long-term nonprogressive human immunodeficiency virus infection

1 reference

12 December 2020

Nucleotide sequence of the AIDS virus, LAV

1 reference

12 December 2020

Frequent Detection and Isolation of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and at Risk for AIDS

1 reference

12 December 2020

The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus

1 reference

12 December 2020

Lack of induction of antibodies specific for conserved, discontinuous epitopes of HIV-1 envelope glycoprotein by candidate AIDS vaccines

1 reference

12 December 2020

Protection by attenuated simian immunodeficiency virus in macaques against challenge with virus-infected cells.

1 reference

12 December 2020

Human immunodeficiency virus infection among high-risk seronegative prostitutes in Nairobi

1 reference

12 December 2020

Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection

1 reference

12 December 2020

Cross-neutralizing activity against divergent human immunodeficiency virus type 1 isolates induced by the gp41 sequence ELDKWAS.

1 reference

12 December 2020

Major expansion of CD8+ T cells with a predominant V beta usage during the primary immune response to HIV.

1 reference

12 December 2020

Whether and when an AIDS vaccine?

1 reference

12 December 2020

Preclinical efficacy of a prototype DNA vaccine: Enhanced protection against antigenic drift in influenza virus

1 reference

12 December 2020

Dilemma of neutralization resistance of HIV-1 field isolates and vaccine development.

1 reference

12 December 2020

Biodegradable microparticles as controlled release antigen delivery systems.

1 reference

12 December 2020

Construction of genetically defined double aro mutants of Salmonella typhi

1 reference

12 December 2020

Reduced rate of disease development after HIV-2 infection as compared to HIV-1

1 reference

12 December 2020

Pathogenesis of human immunodeficiency virus infection

1 reference

12 December 2020

Can the immune response control HIV infection?

1 reference

12 December 2020

Incomplete protection, but suppression of virus burden, elicited by subunit simian immunodeficiency virus vaccines

1 reference

12 December 2020

Clearance of HIV infection in a perinatally infected infant

1 reference

12 December 2020

Long-term HIV-1 infection without immunologic progression

1 reference

12 December 2020

Cross-clade neutralization of primary isolates of human immunodeficiency virus type 1 by human monoclonal antibodies and tetrameric CD4-IgG.

1 reference

12 December 2020

Detection of diverse HIV-1 genetic subtypes in the USA

1 reference

12 December 2020

Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients

1 reference

12 December 2020

Virus burden in long-term survivors of human immunodeficiency virus (HIV) infection is a determinant of anti-HIV CD8+ lymphocyte activity

1 reference

12 December 2020

Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells

1 reference

12 December 2020

Human immunodeficiency virus type 1 neutralization is determined by epitope exposure on the gp120 oligomer

1 reference

12 December 2020

Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion

1 reference

12 December 2020

Molecular Characterization of Human T-Cell Leukemia (Lymphotropic) Virus Type III in the Acquired Immune Deficiency Syndrome

1 reference

12 December 2020

Cholera toxin adjuvant promotes long-term immunological memory in the gut mucosa to unrelated immunogens after oral immunization

1 reference

12 December 2020

Pathogenicity of live, attenuated SIV after mucosal infection of neonatal macaques

1 reference

12 December 2020

Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody

1 reference

12 December 2020

Natural protection against HIV-1 infection provided by HIV-2.

1 reference

12 December 2020

An IL-12-based vaccination method for preventing fibrosis induced by schistosome infection

1 reference

12 December 2020

High levels of anti-human immunodeficiency virus type 1 (HIV-1) memory cytotoxic T-lymphocyte activity and low viral load are associated with lack of disease in HIV-1-infected long-term nonprogressors.

1 reference

12 December 2020

Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS)

1 reference

12 December 2020

Measuring vaccine-induced HIV neutralization: report of a workshop.

1 reference

12 December 2020

Scientific and social issues of human immunodeficiency virus vaccine development

1 reference

12 December 2020

Immunization of chimpanzees confers protection against challenge with human immunodeficiency virus

1 reference

12 December 2020

Comparison of adjuvant formulations for cytotoxic T cell induction using synthetic peptides.

1 reference

12 December 2020

Efficacy studies on a canarypox-rabies recombinant virus

1 reference

12 December 2020

Immunization with envelope subunit vaccine products elicits neutralizing antibodies against laboratory-adapted but not primary isolates of human immunodeficiency virus type 1. The National Institute of Allergy and Infectious Diseases AIDS Vaccine Ev

1 reference

12 December 2020

Exploring transgenic plants as a new vaccine source

1 reference

12 December 2020

Reexamining AIDS research priorities

1 reference

12 December 2020

Viral dynamics in human immunodeficiency virus type 1 infection

1 reference

12 December 2020

Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01540910

1 reference

Dimensions Publication ID

26 September 2017

1007271979

0 references

1 reference